【医療ダイエット】医師も飲んでる！初心者におすすめの痩せ薬”メトホルミン”について専門医が徹底解説

👉️Manjaro's online consultations are available via [Official LINE] https://lstep.app/zXFPzsp ◆━━━━━━━━━━━━━━━━━━◆ \ Achieve your last diet ever! 🔥 / ✅ Say goodbye to strict exercise and diet restrictions! ✅ Over 10,000 successful cases! Knowledge and clinical experience based on medical evidence ✅ Thorough follow-up after prescription \ For consultations and online consultations, please use our official LINE 💁‍♂️ / Dr. Kenshin will respond directly! https://lstep.app/zXFPzsp ▼Video Table of Contents▼ 00:00 About this video 00:24 Metformin and Diabetes 02:35 Effects of Metformin 05:35 Side Effects of Metformin 08:40 Who Should Not Take Metformin? 10:54 Comparison with GLP-1 Drugs 12:08 How to Take Metformin 15:57 Interactions with Other Medications 17:19 Summary ●Official LINE https://lstep.app/zXFPzsp ●Instagram   / tsukuba_ken_clinic   ●TikTok   / diet_dr.kenshin   ●Homepage https://tsukuken.clinic 🔹We are recruiting team members | Doctor and Staff Recruitment Tsukuba Ken Clinic is committed to new forms of healthcare, including online private consultations, online insured consultations, general outpatient care, and preventive medicine. We value flexible responses and teamwork to deliver the necessary medical care to each individual patient, rather than a one-size-fits-all approach. We are looking for colleagues who want to grow together and create better healthcare. 📍【Recruitment Information & Application Here】 ▶︎ https://tsukuken.clinic/recruit/ *Please check the link above for details on specific job roles, duties, and working styles. ───────────── ●Supplementary Notes Based on Medical Advertising Guidelines 02:05 Regarding Metformin Being "The Most Used Drug in the World" for Diabetes *Source: The Current and Potential Therapeutic Use of Metformin *Original Paper: https://x.gd/kjoCQ ────────────────── 【About Treatment】(Disclosure of Important Information) 1. About Medical Treatment and Prescriptions Provided at Our Clinic At our clinic, type 2 diabetes medications (GLP-1 receptor agonists, SGLT2 inhibitors, metformin, etc.) may be prescribed as private medical treatment (for the purpose of treating obesity) at the discretion of the physician. Since the use of these drugs for the purpose of treating obesity is not approved in Japan, this constitutes off-label use. We make a comprehensive judgment based on the examination, test results, and medical history, and we cannot prescribe them to all patients. 2. Main Purpose and Indications of Treatment All of these drugs are approved for the purpose of controlling blood glucose in type 2 diabetes. The use of this medication for obesity treatment will be carried out only after thorough explanation and informed consent, taking into account domestic and international approval status and academic society guidelines. 3. Individual Differences in Efficacy, Side Effects, and Risks Taking the medication or injections does not necessarily guarantee a consistent weight loss effect. There are significant individual differences in effectiveness, and it is essential to use it in conjunction with lifestyle changes, dietary therapy, and exercise therapy. Side effects such as hypoglycemia and gastrointestinal symptoms may occur; please consult a doctor immediately if you experience any discomfort. 4. Possibility of Tests and Additional Treatments Regular tests (blood, urine, etc.) may be necessary to continue treatment. Consultation fees, test fees, and additional medication costs may be incurred separately. 5. Precautions Regarding Private Medical Treatment Prescriptions for obesity treatment are not covered by health insurance (fully self-funded). Because it is an off-label use, it may not be covered by the national drug side effect relief system. 6. Comparison with Other Treatments and Guarantees This treatment is merely one option, and we do not guarantee that it is superior to other medical institutions or other treatments. Treatment effectiveness and the risk of side effects vary from person to person, and the expected results are not always guaranteed. ────────────────── ●GLP-1 Receptor Agonist (Oral Medication: Rybelsus) 【Treatment Details】 Rybelsus is an oral GLP-1 receptor agonist used to control blood glucose levels in type 2 diabetes. At our hospital, it may be prescribed for obesity treatment at the doctor's discretion (off-label use). Weight loss is expected due to its appetite-suppressing effect and sustained feeling of fullness. 【Dosage and Administration】 Take once daily before breakfast with 120 mL or less of water. Avoid eating or drinking for 30 minutes after taking the medication (to maximize its effect). The initial dose is 3 mg, increased to 7 mg after one month, and can be increased up to 14 mg as needed. [Standard Costs] Rybelsus 3mg 30-day supply: ¥8,480 7mg 30-day supply: ¥18,480 14mg 30-day supply: ¥26,980 [Main Risks and Side Effects] Gastrointestinal symptoms (nausea, vomiting, diarrhe...